Enzyme immunoassay for the specific and quantitative determination of free Vedolizumab (Entyvio®) in serum and plasma.
The solid phase (MTP) is coated by a highly specific monoclonal antibody directed against Vedolizumab. Therefore any cross reactivity to the other therapeutical monoclonal antibodies is excluded.
Reference: IG-AB116
Barcode: 8682754930349
Legal Status: CE-Mark
Intended Use: This kit has been developed for the measurement of drug levels in research and diagnostic uses. It is suitable for Therapeutical Drug Monitoring (TDM) purposes.
Assay Design:
Related Documents
Entyvio® is a trademark of Takeda Pharmaceuticals Inc.
